Seeing Is Believing
VKTX is currently covered by 6 analysts with an average potential upside of $8.83 (93.5%) backed by displayed 27 price targets and 48 ratings.
Analysts average stock forecasts to be materialized ratio is 69.15% with an average time for these price targets to be met of 395.83 days.
Highest price target for VKTX is 25, Lowest price target is 2, average price target is 13.5.
Most recent stock forecast was given by ANNABEL SAMIMY from STIFEL on 08-Aug-2023. First documented stock forecast 21-Nov-2017.
Currently, out of the existing stock ratings of VKTX - 21 which are a Buy (100%)
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average time for PT to be met
Performance score
Buy
30
$18.93 (171.00%)
30
1 months 22 days ago
1/4 (25%)
$10.22 (70.14%)
45
Buy
32
$20.93 (189.07%)
32
3 months 3 days ago
0/2 (0%)
$16.62 (108.26%)
Buy
37
$25.93 (234.24%)
35
4 months 13 days ago
5/7 (71.43%)
$8.29 (95.91%)
243
Buy
40
$28.93 (261.34%)
30
4 months 14 days ago
1/3 (33.33%)
$12.82 (77.08%)
54
Buy
36
$24.93 (225.20%)
31
4 months 14 days ago
1/3 (33.33%)
$13.14 (108.92%)
120
What is VKTX (Viking Therapeutics) average time for price targets to be met?
Which analyst has the current highest performing score on VKTX (Viking Therapeutics) with a proven track record?
Which analyst has the most public recommendations on VKTX (Viking Therapeutics)?
Which analyst is the currently most bullish on VKTX (Viking Therapeutics)?
Which analyst is the currently most reserved on VKTX (Viking Therapeutics)?